Ocular Therapeutix, a drugs company for eye problems formerly known as I-Therapeutix, has raised $14m in its series D round round from a consortium led by Ascension Health Ventures, the corporate venturing unit of Ascension Health hospitals group.
Tara Butler, investment director at Ascension Health Ventures, which manages $325m on behalf of 200 acute care hospitals in the US, said: "Ocular Therapeutix is developing an exciting platform of products that promises to meet prevalent medical and surgical needs within a variety ophthalmic disorders."
Ocular previously raised $15m in June 2009 from venture capital firm Polaris Venture Partners, SV Life Sciences and Versant Ventures. The B round raised $6m in March 2008 from SV and Versant and A round raised $1m.